ELDN

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to innovating therapies for patients with autoimmune diseases and amyotrophic lateral sclerosis (ALS), particularly those in need of organ or cell transplantation. Based in Irvine, California, Eledon is advancing its proprietary drug candidates through clinical trials, aiming to address significant unmet medical needs in these patient populations. With a robust pipeline and a strategic focus on enhancing transplant outcomes, Eledon is positioned to make a meaningful impact in the biopharmaceutical landscape.